Anticoagulant-induced Bleeding: Clinical Trials

4 trials for Anticoagulant-induced Bleeding, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1
Phase 31Completed 1

Follow Anticoagulant-induced Bleeding: new trials by email Literature Review of Anticoagulant-induced Bleeding trials Research Report on Anticoagulant-induced Bleeding

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
Rivaroxaban 20 MG [Xarelto], Aspirin 300mg, Acenocoumarol Oral Tablet - Venous Thromboembolism, Anticoagulant-induced Bleeding
Phase 2 / Phase 3CompletedInstituto Mexicano del Seguro Social582021-01-032022-08-25
The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.
Enoxaparin - Fractures, Bone, CKD Stage 4
Phase 2CompletedHospital Civil de Guadalajara612019-03-012025-01-28
The Randomized OPTIMAL-ACT Trial
Unfractionated heparin - Coronary Artery Disease, Ischemic Heart Disease
Phase 2CompletedMayo Clinic1802019-02-082023-04-04
Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
Heparin and Rivaroxaban - Liver Cirrhosis, Portal Hypertension
Phase 1 / Phase 2CompletedFirst Affiliated Hospital Xi'an Jiaotong University702018-02-122021-08-26

Narrower conditions

Hemorrhage (2)  ·  Thrombosis (2)  ·  Venous Thrombosis (2)  ·  Angina, Unstable (1)  ·  Coronary Artery Disease (1)  ·  Fractures, Bone (1)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)  ·  Myocardial Ischemia (1)  ·  Pulmonary Embolism (1)  ·  Renal Insufficiency, Chronic (1)  ·  Venous Thromboembolism (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Embolism and Thrombosis (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Angina Pectoris (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Chest Pain (1)  ·  Chronic Disease (1)  ·  Coronary Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Embolism (1)  ·  Female Urogenital Diseases (1)

Interventions

Heparin (2)  ·  Rivaroxaban (2)  ·  Acenocoumarol (1)  ·  Aspirin (1)  ·  Enoxaparin (1)  ·  acarboxyprothrombin (1)

Sponsors

First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Hospital Civil de Guadalajara (1)  ·  Instituto Mexicano del Seguro Social (1)  ·  Mayo Clinic (1)

Countries

Mexico (2)  ·  China (1)  ·  United States (1)

Top investigators

Shahyar M Gharacholou, MD, MSc (1)

Results publications

PMID 41291481